Arcadia Biosciences (RKDA) Net Margin (2016 - 2024)
Arcadia Biosciences (RKDA) has disclosed Net Margin for 12 consecutive years, with 88.63% as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Net Margin fell 6066.0% year-over-year to 88.63%, compared with a TTM value of 32.5% through Sep 2025, down 7915.0%, and an annual FY2024 reading of 53.93%, down 3550.0% over the prior year.
- Net Margin was 88.63% for Q3 2025 at Arcadia Biosciences, down from 34.43% in the prior quarter.
- Across five years, Net Margin topped out at 623.42% in Q4 2023 and bottomed at 385.84% in Q2 2021.
- Average Net Margin over 5 years is 64.77%, with a median of 74.52% recorded in 2025.
- The sharpest move saw Net Margin skyrocketed 306221bps in 2021, then crashed -62556bps in 2024.
- Year by year, Net Margin stood at 373.53% in 2021, then skyrocketed by 105bps to 17.81% in 2022, then soared by 3401bps to 623.42% in 2023, then plummeted by -100bps to 2.14% in 2024, then crashed by -4042bps to 88.63% in 2025.
- Business Quant data shows Net Margin for RKDA at 88.63% in Q3 2025, 34.43% in Q2 2025, and 2.14% in Q4 2024.